Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Postepy Higieny I Medycyny Doswiadczalnej (Online)|December 23, 2014
[Pro-angiogenic cytokines in systemic sclerosis]Ewa Robak, Zofia GerliczArchives of Medical Science : AMS|May 22, 2019
Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosisEwa Robak, Zofia Gerlicz-Kowalczuk, Bozena Dziankowska-Bartkowiak, et al.European Cytokine Network|May 11, 2013
Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patientsEwa Robak, Lilianna Kulczycka-Siennicka, Zofia Gerlicz, et al.Archives of Medical Science : AMS|February 1, 2012
Angiogenin and SDF-1α serum concentration in patients with systemic sclerosis in relation to clinical statusBożena Dziankowska-Bartkowiak, Zofia Gerlicz-Kowalczuk, Elżbieta WaszczykowskaDermatology (Basel, Switzerland)|March 8, 2014
Disturbed balance between serum levels of receptor tyrosine kinases Tie-1, Tie-2 and angiopoietins in systemic sclerosisZofia Gerlicz, Bozena Dziankowska-Bartkowiak, Elzbieta Dziankowska-Zaborszczyk, et al.Postepy Dermatologii I Alergologii|February 10, 2018
Circulating angiostatin serum level in patients with systemic sclerosisZofia Gerlicz-Kowalczuk, Elzbieta Dziankowska-Zaborszczyk, Bożena Dziankowska-BartkowiakBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 25, 2010
New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignanciesTadeusz Robak, Ewa RobakPostepy Higieny I Medycyny Doswiadczalnej (Online)|October 23, 2010
[Rosacea]Ewa Robak, Lilianna KulczyckaExpert Opinion on Investigational Drugs|May 23, 2012
Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disordersTadeusz Robak, Ewa RobakCancers|February 13, 2026
Cutaneous Adverse Effects in Patients Treated with BTK InhibitorsEwa Robak, Tadeusz RobakPageof 8